Literature DB >> 26021841

Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.

Richard Macey1, Tanya Walsh, Paul Brocklehurst, Alexander R Kerr, Joseph L Y Liu, Mark W Lingen, Graham R Ogden, Saman Warnakulasuriya, Crispian Scully.   

Abstract

BACKGROUND: Oral squamous cell carcinoma is the most common form of malignancy of the lip and oral cavity, often being proceeded by potentially malignant disorders (PMD). Early detection can reduce the malignant transformation of PMD and can improve the survival rate for oral cancer. The current standard of scalpel biopsy with histology is painful for patients and involves a delay whilst histology is completed; other tests are available that are unobtrusive and provide immediate results. PRIMARY
OBJECTIVE: To estimate the diagnostic accuracy of index tests for the detection of oral cancer and PMD of the lip and oral cavity, in people presenting with clinically evident lesions. SECONDARY
OBJECTIVE: To estimate the relative accuracy of the different index tests. SEARCH
METHODS: The electronic databases were searched on 30 April 2013. We searched MEDLINE (OVID) (1946 to April 2013) and four other electronic databases (the Cochrane Diagnostic Test Accuracy Studies Register, the Cochrane Oral Health Group's Trials Register, EMBASE (OVID) and MEDION (Ovid)). There were no restrictions on language in the searches of the electronic databases. We conducted citation searches and screened reference lists of included studies for additional references. SELECTION CRITERIA: We selected studies that reported the diagnostic test accuracy of the following index tests when used as an adjunct to conventional oral examination in detecting PMD or oral squamous cell carcinoma of the lip or oral cavity: vital staining, oral cytology, light-based detection and oral spectroscopy, blood or saliva analysis (which test for the presence of biomarkers in blood or saliva). DATA COLLECTION AND ANALYSIS: Two review authors independently screened titles and abstracts for relevance. Eligibility, data extraction and quality assessment were carried out by at least two authors, independently and in duplicate. Studies were assessed for methodological quality using QUADAS-2. Meta-analysis was used to combine the results of studies for each index test using the bivariate approach to estimate the expected values of sensitivity and specificity. MAIN
RESULTS: We included 41 studies, recruiting 4002 participants, in this review. These studies evaluated the diagnostic accuracy of conventional oral examination with: vital staining (14 studies), oral cytology (13 studies), light-based detection or oral spectroscopy (13 studies). Six studies assessed two combined index tests. There were no eligible diagnostic accuracy studies evaluating blood or salivary sample analysis.The summary estimates for vital staining obtained from the meta-analysis were sensitivity of 0.84 (95% CI 0.74 to 0.90) with specificity of 0.70 (0.59 to 0.79), with 14 studies were included in the meta-analysis. For cytology, sensitivity was 0.91 (0.81 to 0.96) and specificity was 0.91 (0.81 to 0.95) with 12 studies included in the meta-analysis. For light-based detection, sensitivity was 0.91 (0.77 to 0.97) and specificity was 0.58 (0.22 to 0.87) with 11 studies included in the meta-analysis. The relative test accuracy was assessed by adding covariates to the bivariate analysis, no difference in model fit was observed. AUTHORS'
CONCLUSIONS: The overall quality of the included studies was poor. None of the adjunctive tests can be recommended as a replacement for the currently used standard of a scalpel biopsy and histological assessment. Given the relatively high values of the summary estimates of sensitivity and specificity for cytology, this would appear to offer the most potential. Combined adjunctive tests involving cytology warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26021841      PMCID: PMC7087440          DOI: 10.1002/14651858.CD010276.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  122 in total

1.  Cancer: Missing the mark.

Authors:  Lizzie Buchen
Journal:  Nature       Date:  2011-03-24       Impact factor: 49.962

2.  [Toluidine test in the diagnosis of oral malignant neoplasms].

Authors:  M Swider; K Najwer; J Wierzbicki; J Grudzińska
Journal:  Czas Stomatol       Date:  1984-09

3.  Usefulness of fluorescence photography for diagnosis of oral cancer.

Authors:  K Onizawa; H Saginoya; Y Furuya; H Yoshida; H Fukuda
Journal:  Int J Oral Maxillofac Surg       Date:  1999-06       Impact factor: 2.789

4.  Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity--a clinical and histological assessment.

Authors:  Kh Awan; Yh Yang; Pr Morgan; S Warnakulasuriya
Journal:  Oral Dis       Date:  2012-04-24       Impact factor: 3.511

5.  Noninvasive evaluation of oral lesions using depth-sensitive optical spectroscopy.

Authors:  Richard A Schwarz; Wen Gao; Crystal Redden Weber; Cristina Kurachi; J Jack Lee; Adel K El-Naggar; Rebecca Richards-Kortum; Ann M Gillenwater
Journal:  Cancer       Date:  2009-04-15       Impact factor: 6.860

6.  Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection.

Authors:  Noh Jin Park; Hui Zhou; David Elashoff; Bradley S Henson; Dragana A Kastratovic; Elliot Abemayor; David T Wong
Journal:  Clin Cancer Res       Date:  2009-08-25       Impact factor: 12.531

7.  The use of an oral brush biopsy without computer-assisted analysis in the evaluation of oral lesions: a study of 94 patients.

Authors:  Ravi Mehrotra; Mayank Kumar Singh; Shruti Pandya; Mamta Singh
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2008-08

8.  Evaluation of chemiluminescence, toluidine blue and histopathology for detection of high risk oral precancerous lesions: A cross-sectional study.

Authors:  Shweta Ujaoney; Mukta B Motwani; Shirish Degwekar; Vijay Wadhwan; Prajakta Zade; Minal Chaudhary; Vinay Hazarey; Tushar P Thakre; Manju Mamtani
Journal:  BMC Clin Pathol       Date:  2012-03-12

9.  Cytologic and DNA-cytometric early diagnosis of oral cancer.

Authors:  T W Remmerbach; H Weidenbach; N Pomjanski; K Knops; S Mathes; A Hemprich; A Böcking
Journal:  Anal Cell Pathol       Date:  2001       Impact factor: 2.916

10.  Diagnostic value of nucleolar organizer regions (AgNORs) in brush biopsies of suspicious lesions of the oral cavity.

Authors:  Torsten W Remmerbach; Horst Weidenbach; Conrad Müller; Alexander Hemprich; Natalja Pomjanski; Birgit Buckstegge; Alfred Böcking
Journal:  Anal Cell Pathol       Date:  2003       Impact factor: 2.916

View more
  35 in total

Review 1.  Improving Oral Cancer Outcomes with Imaging and Artificial Intelligence.

Authors:  B Ilhan; K Lin; P Guneri; P Wilder-Smith
Journal:  J Dent Res       Date:  2020-03       Impact factor: 6.116

2.  Saliva protein biomarkers and oral squamous cell carcinoma.

Authors:  Leonardo Victor Galvão-Moreira; Maria Carmen Fontoura Nogueira da Cruz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-30       Impact factor: 11.205

3.  Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Young-Hoon Joo; Jae-Keun Cho; Bon Seok Koo; Minsu Kwon; Seong Keun Kwon; Soon Young Kwon; Min-Su Kim; Jeong Kyu Kim; Heejin Kim; Innchul Nam; Jong-Lyel Roh; Young Min Park; Il-Seok Park; Jung Je Park; Sung-Chan Shin; Soon-Hyun Ahn; Seongjun Won; Chang Hwan Ryu; Tae Mi Yoon; Giljoon Lee; Doh Young Lee; Myung-Chul Lee; Joon Kyoo Lee; Jin Choon Lee; Jae-Yol Lim; Jae Won Chang; Jeon Yeob Jang; Man Ki Chung; Yuh-Seok Jung; Jae-Gu Cho; Yoon Seok Choi; Jeong-Seok Choi; Guk Haeng Lee; Phil-Sang Chung
Journal:  Clin Exp Otorhinolaryngol       Date:  2019-02-02       Impact factor: 3.372

4.  Diagnostic adjuncts on oral cancer and precancer: an update for practitioners.

Authors:  S Warnakulasuriya
Journal:  Br Dent J       Date:  2017-11-10       Impact factor: 1.626

5.  Mouth cancer: presentation, detection and referral in primary dental care.

Authors:  M A O Lewis
Journal:  Br Dent J       Date:  2018-11-09       Impact factor: 1.626

6.  'Cytology-on-a-chip' based sensors for monitoring of potentially malignant oral lesions.

Authors:  Timothy J Abram; Pierre N Floriano; Nicolaos Christodoulides; Robert James; A Ross Kerr; Martin H Thornhill; Spencer W Redding; Nadarajah Vigneswaran; Paul M Speight; Julie Vick; Craig Murdoch; Christine Freeman; Anne M Hegarty; Katy D'Apice; Joan A Phelan; Patricia M Corby; Ismael Khouly; Jerry Bouquot; Nagi M Demian; Y Etan Weinstock; Stephanie Rowan; Chih-Ko Yeh; H Stan McGuff; Frank R Miller; Surabhi Gaur; Kailash Karthikeyan; Leander Taylor; Cathy Le; Michael Nguyen; Humberto Talavera; Rameez Raja; Jorge Wong; John T McDevitt
Journal:  Oral Oncol       Date:  2016-07-20       Impact factor: 5.337

7.  Validity of Toluidine Blue test as a diagnostic tool for high risk oral potentially malignant disorders- a multicentre study in Sri Lanka.

Authors:  R D Jayasinghe; P V K S Hettiarachchi; Dilrukshi Amugoda; Menaka Kumaraarachchi; R L P R Liyanage; B S M S Siriwardena; Ranjith Gunasena; A H T S Karunatilake; H K Amarasinghe
Journal:  J Oral Biol Craniofac Res       Date:  2020-08-19

8.  In Vivo Multimodal Optical Imaging: Improved Detection of Oral Dysplasia in Low-Risk Oral Mucosal Lesions.

Authors:  Eric C Yang; Richard A Schwarz; Alexander K Lang; Nancy Bass; Hawraa Badaoui; Imran S Vohra; Katelin D Cherry; Michelle D Williams; Ann M Gillenwater; Nadarajah Vigneswaran; Rebecca R Richards-Kortum
Journal:  Cancer Prev Res (Phila)       Date:  2018-06-14

Review 9.  Screening for mouth cancer: the pros and cons of a national programme.

Authors:  P R Brocklehurst; P M Speight
Journal:  Br Dent J       Date:  2018-11-09       Impact factor: 1.626

Review 10.  Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults.

Authors:  Tanya Walsh; Joseph L Y Liu; Paul Brocklehurst; Anne-Marie Glenny; Mark Lingen; Alexander R Kerr; Graham Ogden; Saman Warnakulasuriya; Crispian Scully
Journal:  Cochrane Database Syst Rev       Date:  2013-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.